{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:04:41Z","timestamp":1793851481088,"version":"4.6.1"},"reference-count":207,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["198454"],"award-info":[{"award-number":["198454"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000014","name":"Canadian Blood Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000014","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000008","name":"Health Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000008","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.blre.2026.101389","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T17:15:38Z","timestamp":1774545338000},"page":"101389","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The humoral pathophysiology of immune thrombocytopenia: How close are we to patient-specific disease treatment?"],"prefix":"10.1016","volume":"77","author":[{"given":"Peter A.A.","family":"Norris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin D.","family":"Won","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan H.","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2026.101389_bb0005","first-page":"1","article-title":"Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura","volume":"38","author":"Harrington","year":"1951","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.blre.2026.101389_bb0010","doi-asserted-by":"crossref","first-page":"433","DOI":"10.7326\/0003-4819-38-3-433","article-title":"Immunologic mechanisms in idiopathic and neonatal thrombocytopenic purpura","volume":"38","author":"Harrington","year":"1953","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.blre.2026.101389_bb0015","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1749-6632.1965.tb18984.x","article-title":"Similarities between known antiplatelet antibodies and the factor responsible for thrombocytopenia in idiopathic purpura. Physiologic, serologic and isotopic studies","volume":"124","author":"Shulman","year":"1965","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.blre.2026.101389_bb0020","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/jth.14419","article-title":"The sensitivity and specificity of platelet autoantibody testing in immune thrombocytopenia: a systematic review and meta-analysis of a diagnostic test","volume":"17","author":"Vrbensky","year":"2019","journal-title":"J Thromb Haemost JTH"},{"key":"10.1016\/j.blre.2026.101389_bb0025","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1182\/blood.V78.10.2619.2619","article-title":"Increased antiplatelet T helper lymphocyte reactivity in patients with autoimmune thrombocytopenia","volume":"78","author":"Semple","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101389_bb0030","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1182\/blood-2006-09-044388","article-title":"Mapping helper T-cell epitopes on platelet membrane glycoprotein IIIa in chronic autoimmune thrombocytopenic purpura","volume":"109","author":"Sukati","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101389_bb0035","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/nm921","article-title":"T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura","volume":"9","author":"Olsson","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.blre.2026.101389_bb0040","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1600-0609.2005.00622.x","article-title":"Cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura","volume":"76","author":"Zhang","year":"2006","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.blre.2026.101389_bb0045","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2022018380","article-title":"The role of CD8+ T cell clones in immune thrombocytopenia","author":"Malik","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101389_bb0050","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1055\/s-0038-1677032","article-title":"Novel murine model of immune Thrombocytopaenia through immunized CD41 knockout mice","volume":"119","author":"Li","year":"2019","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2026.101389_bb0055","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1182\/blood-2009-09-244772","article-title":"A murine model of severe immune thrombocytopenia is induced by antibody- and CD8+ T cell-mediated responses that are differentially sensitive to therapy","volume":"115","author":"Chow","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101389_bb0060","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/ejh.13705","article-title":"T cell-mediated autoimmunity in immune thrombocytopenia","volume":"108","author":"Vrbensky","year":"2022","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.blre.2026.101389_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2020.104096","article-title":"CD4(+) T cell phenotypes in the pathogenesis of immune thrombocytopenia","volume":"351","author":"Kostic","year":"2020","journal-title":"Cell Immunol"},{"key":"10.1016\/j.blre.2026.101389_bb0070","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13045-014-0072-6","article-title":"T cell immune abnormalities in immune thrombocytopenia","volume":"7","author":"Ji","year":"2014","journal-title":"J Hematol OncolJ Hematol Oncol"},{"key":"10.1016\/j.blre.2026.101389_bb0075","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/bjh.12480","article-title":"Cellular immune dysfunction in immune thrombocytopenia (ITP)","volume":"163","author":"McKenzie","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2026.101389_bb0080","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1182\/blood.V83.4.1024.1024","article-title":"Spectrum of Ig classes, specificities, and titers of serum antiglycoproteins in chronic idiopathic thrombocytopenic purpura","volume":"83","author":"He","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101389_bb0085","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/bjh.15404","article-title":"Detection of platelet autoantibodies to identify immune thrombocytopenia: state of the art","volume":"182","author":"Porcelijn","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2026.101389_bb0090","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.tmrv.2020.09.003","article-title":"Evolution and utility of antiplatelet autoantibody testing in patients with immune thrombocytopenia","volume":"34","author":"Porcelijn","year":"2020","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.blre.2026.101389_bb0095","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1203\/00006450-199610000-00017","article-title":"Varicella-associated thrombocytopenia: autoantibodies against platelet surface glycoprotein V","volume":"40","author":"Mayer","year":"1996","journal-title":"Pediatr Res"},{"key":"10.1016\/j.blre.2026.101389_bb0100","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.jtha.2025.02.016","article-title":"Platelet autoantibodies have an impact on the platelet count in patients","volume":"23","author":"Sachs","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2026.101389_bb0105","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1751-553X.2007.00902.x","article-title":"The effect of platelet autoantibodies on the course of the disease and clinical response of patients with idiopathic thrombocytopenic purpura","volume":"30","author":"Sikorska","year":"2008","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.blre.2026.101389_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30094","article-title":"Anti-glycoprotein autoantibodies are related to bleeding severity in children with newly diagnosed ITP and very low platelet counts","volume":"70","author":"Dong","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2026.101389_bb0115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/bloodadvances.2019000868","article-title":"A modern reassessment of glycoprotein-specific direct platelet autoantibody testing in immune thrombocytopenia","volume":"4","author":"Al-Samkari","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.blre.2026.101389_bb0120","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1182\/blood.V96.7.2520","article-title":"Identification of critical antigen-specific mechanisms in the development of immune thrombocytopenic purpura in mice","volume":"96","author":"Nieswandt","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101389_bb0125","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1182\/blood-2005-06-009761","article-title":"Relative efficacy of intravenous immunoglobulin G in ameliorating thrombocytopenia induced by antiplatelet GPIIbIIIa versus GPIbalpha antibodies","volume":"108","author":"Webster","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101389_bb0130","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1182\/blood.V98.4.1095","article-title":"Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia","volume":"98","author":"Teeling","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101389_bb0135","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1182\/blood.2020009497","article-title":"Anti-inflammatory activity of CD44 antibodies in murine immune thrombocytopenia is mediated by Fc\u03b3 receptor inhibition","volume":"137","author":"Norris","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101389_bb0140","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood.2019003770","article-title":"Mechanisms of anti-GPIb\u03b1 antibody-induced thrombocytopenia in mice","volume":"135","author":"Morodomi","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101389_bb0145","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJM197401312900505","article-title":"In vitro platelet phagocytosis by splenic leukocytes in idiopathic thrombocytopenic purpura","volume":"290","author":"McMillan","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2026.101389_bb0150","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJM197405022901803","article-title":"Phagocytosis of antibody-coated platelets by human granulocytes","volume":"290","author":"Handin","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2026.101389_bb0155","first-page":"250","article-title":"In vitro platelet phagocytosis in idiopathic thrombocytopenic purpura","volume":"70","author":"Tsubakio","year":"1983","journal-title":"Acta Haematol"},{"key":"10.1016\/j.blre.2026.101389_bb0160","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-3083.2011.02600.x","article-title":"The isotype of autoantibodies influences the phagocytosis of antibody-coated platelets in autoimmune thrombocytopenic purpura","volume":"74","author":"Hoemberg","year":"2011","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.blre.2026.101389_bb0165","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3324\/haematol.2018.211086","article-title":"Glycoprotein V is a relevant immune target in patients with immune thrombocytopenia","volume":"104","author":"Vollenberg","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2026.101389_bb0170","doi-asserted-by":"crossref","unstructured":"Norris PAA, Segel GB, Burack WR, Sachs UJ, Lissenberg-Thunnissen SN, Vidarsson G, et al. Fc\u03b3RI and Fc\u03b3RIII on splenic macrophages mediate phagocytosis of anti-glycoprotein IIb\/IIIa autoantibody-opsonized platelets in immune thrombocytopenia. Haematologica 2021;106:250\u20134. doi:https:\/\/doi.org\/10.3324\/haematol.2020.248385.","DOI":"10.3324\/haematol.2020.248385"},{"key":"10.1016\/j.blre.2026.101389_bb0175","doi-asserted-by":"crossref","unstructured":"Norris PAA, Tawhidi Z, Sachs UJ, Cserti-Gazdewich CM, Lin Y, Callum JL, et al. Serum from half of immune thrombocytopenia patients trigger macrophage phagocytosis of platelets. Blood Adv 2023:bloodadvances.2022009423. doi:https:\/\/doi.org\/10.1182\/bloodadvances.2022009423.","DOI":"10.1182\/bloodadvances.2022009423"},{"key":"10.1016\/j.blre.2026.101389_bb0180","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF01695692","article-title":"Study of platelet-associated immunoglobulins of IgG, IgM, IgA, and IgE classes and platelet kinetics in 33 patients with idiopathic thrombocytopenic purpura","volume":"69","author":"Movahed Shariat Panahi","year":"1994","journal-title":"Ann Hematol"},{"key":"10.1016\/j.blre.2026.101389_bb0185","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/cyto.b.20067","article-title":"Detection of various platelet-associated immunoglobulins by flow cytometry in idiopathic thrombocytopenic purpura","volume":"68","author":"Nishioka","year":"2005","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.blre.2026.101389_bb0190","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2141.1985.tb02987.x","article-title":"Platelet associated immunoglobulins (PAIgG and PAIgM) in autoimmune thrombocytopenia","volume":"59","author":"Hegde","year":"1985","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2026.101389_bb0195","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2141.1991.tb07954.x","article-title":"Quantification of platelet-bound immunoglobulins of different class and subclass using radiolabelled monoclonal antibodies: assay conditions and clinical application","volume":"77","author":"Tijhuis","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2026.101389_bb0200","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/jcla.1860060306","article-title":"Elevation of platelet-associated IgG in aplastic anemia","volume":"6","author":"Kawaguchi","year":"1992","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.blre.2026.101389_bb0205","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2141.1982.tb03860.x","article-title":"Platelet associated IgG, platelet survival, and platelet sequestration in thrombocytopenic states","volume":"52","author":"Mueller-Eckhardt","year":"1982","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2026.101389_bb0210","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2257.1983.tb00491.x","article-title":"Platelet associated IgG and immune thrombocytopenia in lymphoproliferative and autoimmune disorders","volume":"5","author":"Hegde","year":"1983","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.blre.2026.101389_bb0215","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1182\/blood.V70.6.1722.1722","article-title":"Monoclonal antibody--specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies","volume":"70","author":"Kiefel","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101389_bb0220","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ajh.20309","article-title":"Prospective evaluation of a new platelet glycoprotein (GP)-specific assay (PakAuto) in the diagnosis of autoimmune thrombocytopenia (AITP)","volume":"78","author":"Davoren","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2026.101389_bb0225","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1182\/blood.V112.11.3427.3427","article-title":"Autoantibodies in patients with ITP do not bind to patient-specific epitopes on Platelet glycoproteins","volume":"112","author":"Smith","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101389_bb0230","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.4049\/jimmunol.168.7.3675","article-title":"Spleen is a primary site for activation of platelet-reactive T and B cells in patients with immune thrombocytopenic purpura","volume":"168","author":"Kuwana","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.blre.2026.101389_bb0235","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1182\/bloodadvances.2020001846","article-title":"Platelet autoantibodies in the bone marrow of patients with immune thrombocytopenia","volume":"4","author":"Shrestha","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.blre.2026.101389_bb0240","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1182\/bloodadvances.2017010942","article-title":"Misdiagnosis of primary immune thrombocytopenia and frequency of bleeding: lessons from the McMaster ITP registry","volume":"1","author":"Arnold","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.blre.2026.101389_bb0245","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1182\/bloodadvances.2020003004","article-title":"Misdiagnosed thrombocytopenia in children and adolescents: analysis of the pediatric and adult registry on chronic ITP","volume":"5","author":"Schifferli","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.blre.2026.101389_bb0250","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/bjh.17566","article-title":"Performance characteristics of platelet autoantibody testing for the diagnosis of immune thrombocytopenia using strict clinical criteria","volume":"194","author":"Gabe","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2026.101389_bb0255","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.3324\/haematol.2019.228908","article-title":"Anti-glycoprotein Ib\u03b1 autoantibodies do not impair circulating thrombopoietin levels in immune thrombocytopenia patients","volume":"105","author":"Porcelijn","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2026.101389_bb0260","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1538-7836.2012.04664.x","article-title":"Recommendations for the implementation of platelet autoantibody testing in clinical trials of immune thrombocytopenia","volume":"10","author":"Arnold","year":"2012","journal-title":"J Thromb Haemost JTH"},{"key":"10.1016\/j.blre.2026.101389_bb0265","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"Neunert","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.blre.2026.101389_bb0270","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/imr.12350","article-title":"Mouse and human FcR effector functions","volume":"268","author":"Bruhns","year":"2015","journal-title":"Immunol Rev"},{"key":"10.1016\/j.blre.2026.101389_bb0275","doi-asserted-by":"crossref","unstructured":"Bussel JB, Patel V, Dunbar C, Lemery S, Tibbs K, Watts M, et al. GMA161 treatment of refractory ITP: efficacy of Fc\u03b3-RIII blockade. Blood 2006;108:1074 LP \u2013 1074.","DOI":"10.1182\/blood.V108.11.1074.1074"},{"key":"10.1016\/j.blre.2026.101389_bb0280","doi-asserted-by":"crossref","unstructured":"Nakar CT, Bussel JB. 3G8 and GMA161, anti Fc\u03b3RIII inhibitory monoclonal antibodies in the treatment of chronic refractory ITP. (summary of 2 pilot studies). Blood 2009;114:2404 LP \u2013 2404.","DOI":"10.1182\/blood.V114.22.2404.2404"},{"key":"10.1016\/j.blre.2026.101389_bb0285","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1056\/NEJM198605083141907","article-title":"Treatment of refractory immune thrombocytopenic purpura with an anti-fc gamma-receptor antibody","volume":"314","author":"Clarkson","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2026.101389_bb0290","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1182\/blood-2015-08-664656","article-title":"Monovalent fc receptor blockade by an anti-Fcgamma receptor\/albumin fusion protein ameliorates murine ITP with abrogated toxicity","volume":"127","author":"Yu","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101389_bb0295","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1182\/bloodadvances.2023012155","article-title":"Human fc gamma receptor IIIA blockade inhibits platelet destruction in a humanized murine model of ITP","volume":"8","author":"Gil Gonzalez","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.blre.2026.101389_bb0300","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1084\/jem.186.7.1027","article-title":"A critical role for Syk in signal transduction and phagocytosis mediated by Fcgamma receptors on macrophages","volume":"186","author":"Crowley","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.blre.2026.101389_bb0305","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1182\/blood-2008-07-166439","article-title":"Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk","volume":"113","author":"Podolanczuk","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101389_bb0310","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/ajh.25125","article-title":"Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: results of two phase 3, randomized, placebo-controlled trials","volume":"93","author":"Bussel","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2026.101389_bb0315","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/bjh.18582","article-title":"Fostamatinib for the treatment of Japanese patients with primary immune thrombocytopenia: a phase 3, placebo-controlled, double-blind, parallel-group study","volume":"200","author":"Kuwana","year":"2023","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2026.101389_bb0320","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1056\/NEJMoa2110297","article-title":"Rilzabrutinib, an Oral BTK inhibitor, in immune thrombocytopenia","volume":"386","author":"Kuter","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2026.101389_bb0325","doi-asserted-by":"crossref","unstructured":"Kuter DJ, Bussel JB, Ghanima W, Cooper N, Gernsheimer T, Lambert MP, et al. Rilzabrutinib versus placebo in adults and adolescents with persistent or chronic immune thrombocytopenia: LUNA 3 phase III study. Ther Adv Hematol 2023;14:20406207231205431. doi:https:\/\/doi.org\/10.1177\/20406207231205431.","DOI":"10.1177\/20406207231205431"},{"key":"10.1016\/j.blre.2026.101389_bb0330","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1182\/blood.2024027336","article-title":"Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 study","volume":"145","author":"Kuter","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101389_bb0335","doi-asserted-by":"crossref","unstructured":"Jongstra-Bilen J, Puig Cano A, Hasija M, Xiao H, Smith CIE, Cybulsky MI. Dual functions of Bruton's tyrosine kinase and Tec kinase during Fcgamma receptor-induced signaling and phagocytosis. J Immunol Baltim Md 1950 2008;181:288\u201398. doi:https:\/\/doi.org\/10.4049\/jimmunol.181.1.288.","DOI":"10.4049\/jimmunol.181.1.288"},{"key":"10.1016\/j.blre.2026.101389_bb0340","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1074\/jbc.M115.687251","article-title":"Analysis of the effects of the Bruton's tyrosine kinase (Btk) inhibitor Ibrutinib on monocyte Fc\u03b3 receptor (Fc\u03b3R) function","volume":"291","author":"Ren","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2026.101389_bb0345","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood-2003-01-0023","article-title":"IVIg-mediated amelioration of murine ITP via FcgammaRIIB is independent of SHIP1, SHP-1, and Btk activity","volume":"102","author":"Crow","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101389_bb0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1074-7613(00)80153-3","article-title":"BLNK: connecting Syk and Btk to calcium signals","volume":"12","author":"Kurosaki","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.blre.2026.101389_bb0355","doi-asserted-by":"crossref","unstructured":"Suzuki T, Kono H, Hirose N, Okada M, Yamamoto T, Yamamoto K, et al. Differential involvement of Src family kinases in fc gamma receptor-mediated phagocytosis. J Immunol Baltim Md 1950 2000;165:473\u201382. doi:https:\/\/doi.org\/10.4049\/jimmunol.165.1.473.","DOI":"10.4049\/jimmunol.165.1.473"},{"key":"10.1016\/j.blre.2026.101389_bb0360","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1182\/blood-2014-06-583294","article-title":"Ibrutinib treatment affects collagen and von Willebrand factor-dependent platelet functions","volume":"124","author":"Levade","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101389_bb0365","doi-asserted-by":"crossref","first-page":"5557","DOI":"10.1182\/bloodadvances.2024012713","article-title":"Selective Btk inhibition by PRN1008\/PRN473 blocks human CLEC-2, and PRN473 reduces venous thrombosis formation in mice","volume":"8","author":"Smith","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.blre.2026.101389_bb0370","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/bjh.19858","article-title":"Inhibition of FcRn with rozanolixizumab in adults with immune thrombocytopenia: two randomised, double-blind, placebo-controlled phase 3 studies and their open-label extension","volume":"206","author":"Cooper","year":"2025","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2026.101389_bb0375","doi-asserted-by":"crossref","unstructured":"Broome CM, McDonald V, Miyakawa Y, Carpenedo M, Kuter DJ, Al-Samkari H, et al. Efficacy and safety of the neonatal fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial. Lancet 2023;402:1648\u201359. doi:https:\/\/doi.org\/10.1016\/S0140-6736(23)01460-5.","DOI":"10.1016\/S0140-6736(23)01460-5"},{"key":"10.1016\/j.blre.2026.101389_bb0380","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s40261-024-01380-0","article-title":"Pharmacokinetics and pharmacodynamics of Nipocalimab, a neonatal fc receptor blocker, in healthy Japanese volunteers","volume":"44","author":"Matsushima","year":"2024","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.blre.2026.101389_bb0385","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.3389\/fimmu.2019.02237","article-title":"Genetic variation in low-to-medium-affinity Fc\u03b3 receptors: functional consequences, disease associations, and opportunities for personalized medicine","volume":"10","author":"Nagelkerke","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.blre.2026.101389_bb0390","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12815","article-title":"Comments on and assessments of \u201cassociations between FCGR polymorphisms and immune thrombocytopenia: a meta-analysis\u201d","volume":"91","author":"Gholami","year":"2020","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.blre.2026.101389_bb0395","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1182\/blood-2007-03-079913","article-title":"Copy number variation of the activating FCGR2C gene predisposes to idiopathic thrombocytopenic purpura","volume":"111","author":"Breunis","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101389_bb0400","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/bloodadvances.2019000068","article-title":"Transient and chronic childhood immune thrombocytopenia are distinctly affected by fc-\u03b3 receptor polymorphisms","volume":"3","author":"Schmidt","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.blre.2026.101389_bb0405","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1046\/j.1365-2141.1999.01218.x","article-title":"A prospective study of protein-specific assays used to investigate idiopathic thrombocytopenic purpura","volume":"104","author":"Warner","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2026.101389_bb0410","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1046\/j.1365-2141.2003.04509.x","article-title":"The IgG subclasses of platelet-associated autoantibodies directed against platelet glycoproteins IIb\/IIIa in patients with idiopathic thrombocytopenic purpura","volume":"122","author":"Chan","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2026.101389_bb0415","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.blre.2026.101389_bb0420","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1073\/pnas.1418812112","article-title":"Structure of Fc\u03b3RI in complex with fc reveals the importance of glycan recognition for high-affinity IgG binding","volume":"112","author":"Lu","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2026.101389_bb0425","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.4049\/jimmunol.1200501","article-title":"Impact of immune complex size and glycosylation on IgG binding to human Fc\u03b3Rs","volume":"190","author":"Lux","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.blre.2026.101389_bb0430","doi-asserted-by":"crossref","first-page":"16478","DOI":"10.1074\/jbc.M100351200","article-title":"Recognition of IgG by Fcgamma receptor. The role of fc glycosylation and the binding of peptide inhibitors","volume":"276","author":"Radaev","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2026.101389_bb0435","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/jmr.2155","article-title":"Avidity confers Fc\u03b3R binding and immune effector function to aglycosylated immunoglobulin G1","volume":"25","author":"Nesspor","year":"2012","journal-title":"J Mol Recognit JMR"},{"key":"10.1016\/j.blre.2026.101389_bb0440","doi-asserted-by":"crossref","first-page":"26733","DOI":"10.1074\/jbc.M202069200","article-title":"Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity","volume":"277","author":"Shields","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2026.101389_bb0445","doi-asserted-by":"crossref","unstructured":"Dekkers G, Treffers L, Plomp R, Bentlage AEH, de Boer M, Koeleman CAM, et al. Decoding the human immunoglobulin G-glycan repertoire reveals a spectrum of fc-receptor- and complement-mediated-effector activities. Front Immunol 2017;8:877. doi:https:\/\/doi.org\/10.3389\/fimmu.2017.00877.","DOI":"10.3389\/fimmu.2017.00877"},{"key":"10.1016\/j.blre.2026.101389_bb0450","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.molimm.2017.12.006","article-title":"Conserved Fc\u03b3R- glycan discriminates between fucosylated and afucosylated IgG in humans and mice","volume":"94","author":"Dekkers","year":"2018","journal-title":"Mol Immunol"},{"key":"10.1016\/j.blre.2026.101389_bb0455","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jim.2005.08.009","article-title":"IgG subclass-independent improvement of antibody-dependent cellular cytotoxicity by fucose removal from Asn297-linked oligosaccharides","volume":"306","author":"Niwa","year":"2005","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.blre.2026.101389_bb0460","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1182\/blood-2013-09-527978","article-title":"A prominent lack of IgG1-fc fucosylation of platelet alloantibodies in pregnancy","volume":"123","author":"Kapur","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101389_bb0465","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1038\/s41598-020-59651-7","article-title":"IgG-fc glycosylation before and after rituximab treatment in immune thrombocytopenia","volume":"10","author":"Schmidt","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.blre.2026.101389_bb0470","article-title":"N-glycan profiling alterations of serum and immunoglobulin G in immune thrombocytopenia","volume":"36","author":"Wang","year":"2022","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.blre.2026.101389_bb0475","doi-asserted-by":"crossref","first-page":"24045","DOI":"10.1038\/s41598-021-03196-w","article-title":"A functional spleen contributes to afucosylated IgG in humans","volume":"11","author":"Wojcik","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.blre.2026.101389_bb0480","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1074\/mcp.M114.038513","article-title":"Copy number analysis of the murine platelet proteome spanning the complete abundance range","volume":"13","author":"Zeiler","year":"2014","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.blre.2026.101389_bb0485","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1365-2141.1995.tb05266.x","article-title":"Reactivity of autoantibodies from chronic ITP patients with recombinant glycoprotein IIIa peptides","volume":"91","author":"Bowditch","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2026.101389_bb0490","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1182\/blood.V97.7.2171","article-title":"Autoantibodies to alpha(IIb)beta(3) in patients with chronic immune thrombocytopenic purpura bind primarily to epitopes on alpha(IIb)","volume":"97","author":"McMillan","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101389_bb0495","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1046\/j.1365-2141.2002.03751.x","article-title":"Many alphaIIbbeta3 autoepitopes in chronic immune thrombocytopenic purpura are localized to alphaIIb between amino acids L1 and Q459","volume":"118","author":"McMillan","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2026.101389_bb0500","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1182\/blood.V98.6.1819","article-title":"Platelet-associated anti-GPIIb-IIIa autoantibodies in chronic immune thrombocytopenic purpura recognizing epitopes close to the ligand-binding site of glycoprotein (GP) IIb","volume":"98","author":"Kosugi","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101389_bb0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103040","article-title":"Autologous platelet scintigraphy and clinical outcome of splenectomy in immune thrombocytopenia: a systematic review and meta-analysis","volume":"153","author":"Amini","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.blre.2026.101389_bb0510","article-title":"Anti-glycoprotein antibodies and sequestration pattern of indium labeled platelets in immune thrombocytopenia","author":"Amini","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.blre.2026.101389_bb0515","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1600-0609.2011.01718.x","article-title":"Autoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP)","volume":"88","author":"Najaoui","year":"2012","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.blre.2026.101389_bb0520","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/MOH.0000000000000447","article-title":"Pathophysiology of immune thrombocytopenia","volume":"25","author":"Li","year":"2018","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.blre.2026.101389_bb0525","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1038\/s41598-018-38086-1","article-title":"Multiple concomitant mechanisms contribute to low platelet count in patients with immune thrombocytopenia","volume":"9","author":"Grodzielski","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.blre.2026.101389_bb0530","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3324\/haematol.2019.236117","article-title":"Autoantibody-mediated desialylation impairs human thrombopoiesis and platelet lifespan","volume":"106","author":"Marini","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2026.101389_bb0535","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.3324\/haematol.2021.279751","article-title":"Antiplatelet antibody predicts platelet desialylation and apoptosis in immune thrombocytopenia","volume":"107","author":"Zheng","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2026.101389_bb0540","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0092-8674(00)80983-6","article-title":"Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor","volume":"84","author":"Savage","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.blre.2026.101389_bb0545","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0021-9258(18)48503-1","article-title":"Glycoproteins V and Ib-IX form a noncovalent complex in the platelet membrane","volume":"267","author":"Modderman","year":"1992","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.blre.2026.101389_bb0550","first-page":"1","article-title":"GPIb-IX-V and platelet clearance","author":"Quach","year":"2021","journal-title":"Platelets"},{"key":"10.1016\/j.blre.2026.101389_bb0555","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/j.seminhematol.2007.11.002","article-title":"The pathogenesis of chronic immune thrombocytopenic purpura","volume":"44","author":"McMillan","year":"2007","journal-title":"Semin Hematol"},{"key":"10.1016\/j.blre.2026.101389_bb0560","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1365-2141.1991.tb04530.x","article-title":"Autoantibodies against platelet glycoprotein Ib\/IX: a frequent finding in autoimmune thrombocytopenic purpura","volume":"79","author":"Kiefel","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2026.101389_bb0565","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1182\/blood.V86.10.3789.bloodjournal86103789","article-title":"Extracellular epitopes of platelet glycoprotein Ib alpha reactive with serum antibodies from patients with chronic idiopathic thrombocytopenic purpura","volume":"86","author":"He","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101389_bb0570","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1016\/S0021-9258(17)33044-2","article-title":"Platelet glycocalicin. II. purification and characterization","volume":"251","author":"Okumura","year":"1976","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2026.101389_bb0575","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nm.3770","article-title":"The Ashwell-Morell receptor regulates hepatic thrombopoietin production via JAK2-STAT3 signaling","volume":"21","author":"Grozovsky","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.blre.2026.101389_bb0580","doi-asserted-by":"crossref","first-page":"7737","DOI":"10.1038\/ncomms8737","article-title":"Desialylation is a mechanism of fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia","volume":"6","author":"Li","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.blre.2026.101389_bb0585","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1182\/blood-2009-01-199414","article-title":"Role of sialic acid for platelet life span: exposure of beta-galactose results in the rapid clearance of platelets from the circulation by asialoglycoprotein receptor-expressing liver macrophages and hepatocytes","volume":"114","author":"S\u00f8rensen","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101389_bb0590","doi-asserted-by":"crossref","unstructured":"Deppermann C, Kratofil RM, Peiseler M, David BA, Zindel J, Castanheira FVES, et al. Macrophage galactose lectin is critical for Kupffer cells to clear aged platelets. J Exp Med 2020;217. doi:https:\/\/doi.org\/10.1084\/jem.20190723.","DOI":"10.1084\/jem.20190723"},{"key":"10.1016\/j.blre.2026.101389_bb0595","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1126\/science.1085322","article-title":"Glycosylation restores survival of chilled blood platelets","volume":"301","author":"Hoffmeister","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.blre.2026.101389_bb0600","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0092-8674(02)01253-9","article-title":"The clearance mechanism of chilled blood platelets","volume":"112","author":"Hoffmeister","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.blre.2026.101389_bb0605","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1080\/09537104.2018.1513476","article-title":"Multirefractory primary immune thrombocytopenia; targeting the decreased sialic acid content","volume":"30","author":"Revilla","year":"2019","journal-title":"Platelets"},{"key":"10.1016\/j.blre.2026.101389_bb0610","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/bjh.16459","article-title":"Platelet and immune characteristics of immune thrombocytopaenia patients non-responsive to therapy reveal severe immune dysregulation","volume":"189","author":"Monz\u00f3n Manzano","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2026.101389_bb0615","doi-asserted-by":"crossref","unstructured":"Ram\u00edrez-L\u00f3pez A, \u00c1lvarez Rom\u00e1n MT, Monz\u00f3n Manzano E, Acu\u00f1a P, Arias-Salgado EG, Mart\u00edn Salces M, et al. The importance of platelet glycoside residues in the haemostasis of patients with immune thrombocytopaenia. J Clin Med 2021;10. doi:https:\/\/doi.org\/10.3390\/jcm10081661.","DOI":"10.3390\/jcm10081661"},{"key":"10.1016\/j.blre.2026.101389_bb0620","article-title":"Association of Platelet Desialylation and Circulating Follicular Helper T Cells in patients with thrombocytopenia","volume":"13","author":"Chen","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.blre.2026.101389_bb0625","doi-asserted-by":"crossref","unstructured":"Peng J, Ma S-H, Liu J, Hou Y, Liu X-M, Niu T, et al. Association of autoantibody specificity and response to intravenous immunoglobulin G therapy in immune thrombocytopenia: a multicenter cohort study. J Thromb Haemost JTH 2014;12:497\u2013504. doi:https:\/\/doi.org\/10.1111\/jth.12524.","DOI":"10.1111\/jth.12524"},{"key":"10.1016\/j.blre.2026.101389_bb0630","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3324\/haematol.10667","article-title":"The association between platelet autoantibody specificity and response to intravenous immunoglobulin G in the treatment of patients with immune thrombocytopenia","volume":"92","author":"Go","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2026.101389_bb0635","doi-asserted-by":"crossref","unstructured":"Rogier T, Samson M, Mourey G, Falvo N, Magy-Bertrand N, Ouandji S, et al. Antiplatelet antibodies do not predict the response to intravenous immunoglobulins during immune thrombocytopenia. J Clin Med 2020;9. doi:https:\/\/doi.org\/10.3390\/jcm9061998.","DOI":"10.3390\/jcm9061998"},{"key":"10.1016\/j.blre.2026.101389_bb0640","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1182\/asheducation-2010.1.385","article-title":"Evidence-based mini-review: is indium-labeled autologous platelet scanning predictive of response to splenectomy in patients with chronic immune thrombocytopenia?","volume":"2010","author":"Cuker","year":"2010","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.blre.2026.101389_bb0645","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1182\/blood-2004-03-1168","article-title":"Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications","volume":"104","author":"Kojouri","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101389_bb0650","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1055\/s-0037-1615023","article-title":"The diagnostic value of thrombopoietin level measurements in thrombocytopenia","volume":"79","author":"Porcelijn","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2026.101389_bb0655","doi-asserted-by":"crossref","unstructured":"Kosugi S, Kurata Y, Tomiyama Y, Tahara T, Kato T, Tadokoro S, et al. Circulating thrombopoietin level in chronic immune thrombocytopenic purpura. Br J Haematol 1996;93:704\u20136. doi:https:\/\/doi.org\/10.1046\/j.1365-2141.1996.d01-1702.x.","DOI":"10.1046\/j.1365-2141.1996.d01-1702.x"},{"key":"10.1016\/j.blre.2026.101389_bb0660","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ajh.20104","article-title":"Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodies","volume":"76","author":"Aledort","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2026.101389_bb0665","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1182\/blood-2017-12-820779","article-title":"GPIb\u03b1 is required for platelet-mediated hepatic thrombopoietin generation","volume":"132","author":"Xu","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101389_bb0670","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1182\/bloodadvances.2022007751","article-title":"The interplay between GPIb\/IX antibodies, platelet hepatic sequestration, and TPO levels in patients with chronic ITP","volume":"7","author":"Amini","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.blre.2026.101389_bb0675","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1182\/blood-2017-05-784975","article-title":"Fc-independent immune thrombocytopenia via mechanomolecular signaling in platelets","volume":"131","author":"Quach","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101389_bb0680","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160563","article-title":"Platelet apoptosis in adult immune thrombocytopenia: insights into the mechanism of damage triggered by auto-antibodies","volume":"11","author":"Goette","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.blre.2026.101389_bb0685","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.1016\/S2352-3026(21)00030-2","article-title":"Dexamethasone plus oseltamivir versus dexamethasone in treatment-naive primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial","volume":"8","author":"Sun","year":"2021","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.blre.2026.101389_bb0690","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MOH.0000000000000781","article-title":"New insights into the glycobiology of immune thrombocytopenia","volume":"30","author":"Tiemeyer","year":"2023","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.blre.2026.101389_bb0695","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-94-017-9153-3_3","article-title":"\u03b12\u03b21 Integrin","volume":"819","author":"Madamanchi","year":"2014","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.blre.2026.101389_bb0700","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1182\/blood.V74.1.182.182","article-title":"Collagen-platelet interactions: evidence for a direct interaction of collagen with platelet GPIa\/IIa and an indirect interaction with platelet GPIIb\/IIIa mediated by adhesive proteins","volume":"74","author":"Coller","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101389_bb0705","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1182\/blood.V83.5.1244.1244","article-title":"Platelet adhesion to collagen types I through VIII under conditions of stasis and flow is mediated by GPIa\/IIa (alpha 2 beta 1-integrin)","volume":"83","author":"Saelman","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101389_bb0710","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1423-0410.2006.00839.x","article-title":"A novel antigen-specific capture assay for the detection of platelet antibodies and HPA-1a phenotyping","volume":"91","author":"Meyer","year":"2006","journal-title":"Vox Sang"},{"key":"10.1016\/j.blre.2026.101389_bb0715","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-4889(92)90092-P","article-title":"Platelet adhesion to collagen-coated wells: analysis of this complex process and a comparison with the adhesion to matrigel-coated wells","volume":"1137","author":"Moroi","year":"1992","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.blre.2026.101389_bb0720","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1182\/blood.V82.10.3029.3029","article-title":"Platelet adhesion to cyanogen-bromide fragments of collagen alpha 1(I) under flow conditions","volume":"82","author":"Saelman","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101389_bb0725","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.semarthrit.2008.03.006","article-title":"The long pentraxin 3 and its role in autoimmunity","volume":"39","author":"Ortega-Hernandez","year":"2009","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.blre.2026.101389_bb0730","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1084\/jem.168.1.127","article-title":"Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q","volume":"168","author":"Bindon","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.blre.2026.101389_bb0735","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/0161-5890(95)00064-L","article-title":"Activation of human complement by totally human monoclonal antibodies","volume":"32","author":"Dillman","year":"1995","journal-title":"Mol Immunol"},{"key":"10.1016\/j.blre.2026.101389_bb0740","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1182\/blood-2014-05-579110","article-title":"C-reactive protein enhances IgG-mediated phagocyte responses and thrombocytopenia","volume":"125","author":"Kapur","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101389_bb0745","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1365-2141.1985.tb07477.x","article-title":"Platelet-associated complement in chronic ITP","volume":"60","author":"Kurata","year":"1985","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2026.101389_bb0750","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1182\/blood.V50.6.1129.1129","article-title":"Platelet-bound complement (C3) in immune thrombocytopenia","volume":"50","author":"Hauch","year":"1977","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101389_bb0755","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1182\/blood.V59.5.1023.1023","article-title":"Platelet-associated complement C3 in immune thrombocytopenic purpura","volume":"59","author":"Myers","year":"1982","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101389_bb0760","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1172\/JCI111814","article-title":"Platelet antibodies of the IgM class in immune thrombocytopenic purpura","volume":"75","author":"Cines","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2026.101389_bb0765","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/bjh.13648","article-title":"Classical complement pathway activation in immune thrombocytopenia purpura: inhibition by a novel C1s inhibitor","volume":"173","author":"Peerschke","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2026.101389_bb0770","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00277-017-3215-3","article-title":"Diminished expression of \u03b22-GPI is associated with a reduced ability to mitigate complement activation in anti-GPIIb\/IIIa-mediated immune thrombocytopenia","volume":"97","author":"Zhu","year":"2018","journal-title":"Ann Hematol"},{"key":"10.1016\/j.blre.2026.101389_bb0775","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/cei.13475","article-title":"Complement activation in patients with immune thrombocytopenic purpura according to phases of disease course","volume":"201","author":"Castelli","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.blre.2026.101389_bb0780","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fimmu.2016.00055","article-title":"Systemic lupus erythematosus and deficiencies of early components of the complement classical pathway","volume":"7","author":"Macedo","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.blre.2026.101389_bb0785","doi-asserted-by":"crossref","DOI":"10.1111\/ijlh.13469","article-title":"Features of serum complement C3 and C4 levels in autoimmune hemolytic anemia patients","author":"Wang","year":"2021","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.blre.2026.101389_bb0790","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/rth2.12388","article-title":"Serum complement levels in immune thrombocytopenia: characterization and relation to clinical features","volume":"4","author":"Cheloff","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.blre.2026.101389_bb0795","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1007\/s00277-005-1085-6","article-title":"Complement profile in childhood immune thrombocytopenic purpura: a prospective pilot study","volume":"84","author":"Ohali","year":"2005","journal-title":"Ann Hematol"},{"key":"10.1016\/j.blre.2026.101389_bb0800","doi-asserted-by":"crossref","first-page":"765","DOI":"10.7754\/Clin.Lab.2016.161012","article-title":"Increase of C3a is associated with hemorrhagic propensity in patients with immune thrombocytopenia","volume":"63","author":"Ge","year":"2017","journal-title":"Clin Lab"},{"key":"10.1016\/j.blre.2026.101389_bb0805","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/bjh.13593","article-title":"Higher interleukin 21 level is predictive of relapse in immune thrombocytopenia. Is it associated with activation of the complement system?","volume":"173","author":"Sahip","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2026.101389_bb0810","article-title":"Safety and efficacy of classical complement pathway inhibition with Sutimlimab in chronic immune thrombocytopenia","author":"Broome","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.blre.2026.101389_bb0815","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/978-1-4419-0901-5_7","article-title":"Pattern recognition by pentraxins","volume":"653","author":"Agrawal","year":"2009","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.blre.2026.101389_bb0820","first-page":"10176","article-title":"Recognition of the human antibody-mediated platelet destruction in adult ITP patients by C-reactive protein","volume":"10","author":"Pan","year":"2017","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.blre.2026.101389_bb0825","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1007\/s10238-023-01043-y","article-title":"Expression and prognostic value of C-reactive protein in adult immune thrombocytopenia (ITP) patients","volume":"23","author":"Zhang","year":"2023","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.blre.2026.101389_bb0830","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.thromres.2017.02.012","article-title":"Increased C-reactive protein levels at diagnosis negatively predict platelet count recovery after steroid-treatment in newly diagnosed adult immune thrombocytopenia patients","volume":"152","author":"Rama Kishore","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2026.101389_bb0835","first-page":"5294","article-title":"Testosterone and IL-6 requirements for human C-reactive protein gene expression in transgenic mice","volume":"160","author":"Szalai","year":"1998","journal-title":"J Immunol Baltim Md 1950"},{"issue":"Pt 3","key":"10.1016\/j.blre.2026.101389_bb0840","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1042\/bj3250617","article-title":"Interleukin-6 is necessary, but not sufficient, for induction of the humanC-reactive protein gene in vivo","volume":"325","author":"Weinhold","year":"1997","journal-title":"Biochem J"},{"key":"10.1016\/j.blre.2026.101389_bb0845","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1182\/blood.V84.10.3483.3483","article-title":"Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes","volume":"84","author":"Alles","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101389_bb0850","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/vox.12894","article-title":"Anti-platelet antibody immunoassays in childhood immune thrombocytopenia: a systematic review","volume":"115","author":"Schmidt","year":"2020","journal-title":"Vox Sang"},{"key":"10.1016\/j.blre.2026.101389_bb0855","doi-asserted-by":"crossref","unstructured":"DAMESHEK W, MILLER EB. The megakaryocytes in idiopathic thrombocytopenic purpura, a form of hypersplenism. Blood 1946;1:27\u201350.","DOI":"10.1182\/blood.V1.1.27.27"},{"key":"10.1016\/j.blre.2026.101389_bb0860","doi-asserted-by":"crossref","unstructured":"PISCIOTTA AV, STEFANINI M, DAMESHEK W. Studies on platelets. X. Morphologic characteristics of megakaryocytes by phase contrast microscopy in normals and in patients with idiopathic thrombocytopenic purpura. Blood 1953;8:703\u201323.","DOI":"10.1182\/blood.V8.8.703.703"},{"key":"10.1016\/j.blre.2026.101389_bb0865","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1182\/blood-2003-01-0275","article-title":"Ultrastructural study shows morphologic features of apoptosis and Para-apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic purpura","volume":"103","author":"Houwerzijl","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101389_bb0870","doi-asserted-by":"crossref","first-page":"490","DOI":"10.4103\/0377-4929.56132","article-title":"Megakaryocytic alterations in thrombocytopenia: a bone marrow aspiration study","volume":"52","author":"Muhury","year":"2009","journal-title":"Indian J Pathol Microbiol"},{"key":"10.1016\/j.blre.2026.101389_bb0875","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1080\/09537104.2018.1475637","article-title":"Megakaryocyte apoptosis in immune thrombocytopenia","volume":"29","author":"Vrbensky","year":"2018","journal-title":"Platelets"},{"key":"10.1016\/j.blre.2026.101389_bb0880","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1182\/blood.V74.5.1603.1603","article-title":"Biosynthesis and assembly of platelet GPIIb-IIIa in human megakaryocytes: evidence that assembly between pro-GPIIb and GPIIIa is a prerequisite for expression of the complex on the cell surface","volume":"74","author":"Duperray","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101389_bb0885","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1182\/blood.V94.12.4084","article-title":"Ex vivo cultured megakaryocytes express functional glycoprotein IIb-IIIa receptors and are capable of adenovirus-mediated transgene expression","volume":"94","author":"Faraday","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101389_bb0890","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1182\/blood.V89.11.4047","article-title":"Platelet and megakaryocyte dense granules contain glycoproteins Ib and IIb-IIIa","volume":"89","author":"Youssefian","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101389_bb0895","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2141.1984.tb02184.x","article-title":"Immunological study of in vitro maturation of human megakaryocytes","volume":"56","author":"Vinci","year":"1984","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2026.101389_bb0900","article-title":"The platelet fibrinogen receptor: from megakaryocyte to the mortuary","volume":"1","author":"Floyd","year":"2012","journal-title":"JRSM Cardiovasc Dis"},{"key":"10.1016\/j.blre.2026.101389_bb0905","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1001\/jama.1978.03280500056020","article-title":"Antibody against megakaryocytes in idiopathic thrombocytopenic purpura","volume":"239","author":"McMillan","year":"1978","journal-title":"JAMA"},{"key":"10.1016\/j.blre.2026.101389_bb0910","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/ejh.12528","article-title":"Antibody binding to megakaryocytes in vivo in patients with immune thrombocytopenia","volume":"95","author":"Arnold","year":"2015","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.blre.2026.101389_bb0915","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1182\/blood-2010-02-267435","article-title":"Contributions of TRAIL-mediated megakaryocyte apoptosis to impaired megakaryocyte and platelet production in immune thrombocytopenia","volume":"116","author":"Yang","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101389_bb0920","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3324\/haematol.2014.115634","article-title":"Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro","volume":"100","author":"Iraqi","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2026.101389_bb0925","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/bjh.12832","article-title":"Impaired proplatelet formation in immune thrombocytopenia: a novel mechanism contributing to decreased platelet count","volume":"165","author":"Lev","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2026.101389_bb0930","doi-asserted-by":"crossref","unstructured":"Guo L, Kapur R, Aslam R, Hunt K, Hou Y, Zufferey A, et al. Antiplatelet antibody-induced thrombocytopenia does not correlate with megakaryocyte abnormalities in murine immune thrombocytopenia. Scand J Immunol 2018;88:e12678. https:\/\/doi.org\/https:\/\/doi.org\/10.1111\/sji.12678.","DOI":"10.1111\/sji.12678"},{"key":"10.1016\/j.blre.2026.101389_bb0935","doi-asserted-by":"crossref","unstructured":"Zhang X, Gu S, You L, Xu Y, Zhou D, Chen Y, et al. Gut microbiome and metabolome were altered and strongly associated with Platelet count in adult patients with primary immune thrombocytopenia. Front Microbiol 2020;11:1550. https:\/\/doi.org\/https:\/\/doi.org\/10.3389\/fmicb.2020.01550..","DOI":"10.3389\/fmicb.2020.01550"},{"key":"10.1016\/j.blre.2026.101389_bb0940","doi-asserted-by":"crossref","unstructured":"Wang H, Bi H, Yang M, Wang X, Song C, Yang W, et al. Intestinal flora altered and correlated with interleukin-2\/4 in patients with primary immune thrombocytopenia. Hematology 2023;28:2277501. https:\/\/doi.org\/https:\/\/doi.org\/10.1080\/16078454.2023.2277501.","DOI":"10.1080\/16078454.2023.2277501"},{"key":"10.1016\/j.blre.2026.101389_bb0945","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.thromres.2020.03.012","article-title":"Intestinal microbiota dysbiosis play a role in pathogenesis of patients with primary immune thrombocytopenia","volume":"190","author":"Liu","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2026.101389_bb0950","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2024.101252","article-title":"The intestinal flora: the key to unraveling heterogeneity in immune thrombocytopenia?","volume":"69","author":"Schoenaker","year":"2025","journal-title":"Blood Rev"},{"key":"10.1016\/j.blre.2026.101389_bb0955","doi-asserted-by":"crossref","unstructured":"Zhu G, Yan L, Fang L, Fan C, Sun H, Zhou X, et al. Possible immune mechanisms of gut microbiota and its metabolites in the occurrence and development of immune thrombocytopenia. Front Microbiol 2024;15:1426911. https:\/\/doi.org\/https:\/\/doi.org\/10.3389\/fmicb.2024.1426911.","DOI":"10.3389\/fmicb.2024.1426911"},{"key":"10.1016\/j.blre.2026.101389_bb0960","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2024.101219","article-title":"Gut microbiome composition and dysbiosis in immune thrombocytopenia: a review of literature","volume":"67","author":"Saki","year":"2024","journal-title":"Blood Rev"},{"key":"10.1016\/j.blre.2026.101389_bb0965","series-title":"Fc gamma receptors and phagocytosis in immune thrombocytopenia","author":"Norris","year":"2022"},{"key":"10.1016\/j.blre.2026.101389_bb0970","doi-asserted-by":"crossref","first-page":"33234","DOI":"10.1074\/jbc.272.52.33234","article-title":"Dissection of C1q capability of interacting with IgG. Time-dependent formation of a tight and only partly reversible association","volume":"272","author":"Kaul","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2026.101389_bb0975","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ab.2015.03.012","article-title":"IgG subclass specificity to C1q determined by surface plasmon resonance using Protein L capture technique","volume":"479","author":"Patel","year":"2015","journal-title":"Anal Biochem"},{"issue":"210","key":"10.1016\/j.blre.2026.101389_bb0980","first-page":"1837","article-title":"Development of C1q Affinity Chromatography for the Study of C1q-IgG Interactions","volume":"2023","author":"Marshall","year":"1950","journal-title":"J Immunol Baltim Md"},{"key":"10.1016\/j.blre.2026.101389_bb0985","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.exphem.2016.07.004","article-title":"The spleen dictates platelet destruction, anti-platelet antibody production, and lymphocyte distribution patterns in a murine model of immune thrombocytopenia","volume":"44","author":"Aslam","year":"2016","journal-title":"Exp Hematol"},{"key":"10.1016\/j.blre.2026.101389_bb0990","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1007\/s00277-024-05999-z","article-title":"The effects of complement-independent, autoantibody-induced apoptosis of platelets in immune thrombocytopenia (ITP)","volume":"103","author":"Sun","year":"2024","journal-title":"Ann Hematol"},{"key":"10.1016\/j.blre.2026.101389_bb0995","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2024.109210","article-title":"The role of protein kinase C and the glycoprotein Ib\u03b1 cytoplasmic tail in anti-glycoprotein Ib\u03b1 antibody-induced platelet apoptosis and thrombocytopenia","volume":"244","author":"Zhang","year":"2024","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2026.101389_bb1000","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/bjh.16959","article-title":"Fostamatinib is an effective second-line therapy in patients with immune thrombocytopenia","volume":"190","author":"Boccia","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2026.101389_bb1005","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1182\/blood.2024024250","article-title":"Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice","volume":"144","author":"Gonz\u00e1lez-L\u00f3pez","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101389_bb1010","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/MOH.0000000000000609","article-title":"New insights into IVIg mechanisms and alternatives in autoimmune and inflammatory diseases","volume":"27","author":"Norris","year":"2020","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.blre.2026.101389_bb1015","doi-asserted-by":"crossref","first-page":"2159019","DOI":"10.1080\/09537104.2022.2159019","article-title":"Complement activation negatively affects the platelet response to thrombopoietin receptor agonists in patients with immune thrombocytopenia: a prospective cohort study","volume":"34","author":"\u00c5kesson","year":"2023","journal-title":"Platelets"},{"key":"10.1016\/j.blre.2026.101389_bb1020","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1016\/j.jtha.2025.05.024","article-title":"Clinical evidence for antiglycoprotein IIbIIIa antibody-induced platelet desialylation in primary immune thrombocytopenia","volume":"23","author":"Schramm","year":"2025","journal-title":"J Thromb Haemost JTH"},{"key":"10.1016\/j.blre.2026.101389_bb1025","doi-asserted-by":"crossref","first-page":"11261","DOI":"10.1021\/acs.jmedchem.8b01411","article-title":"Selective Inhibitors of Human Neuraminidase 1 (NEU1)","volume":"61","author":"Guo","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.blre.2026.101389_bb1030","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jtha.2023.01.009","article-title":"Comprehensive analysis of platelet glycoprotein Ib\u03b1 ectodomain glycosylation","volume":"21","author":"Hollenhorst","year":"2023","journal-title":"J Thromb Haemost JTH"},{"key":"10.1016\/j.blre.2026.101389_bb1035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.757633","article-title":"Cryo-Electron Microscopy and Biochemical Analysis Offer Insights Into the Effects of Acidic pH, Such as Occur During Acidosis, on the Complement Binding Properties of C-Reactive Protein","volume":"12","author":"Noone","year":"2021","journal-title":"Front Immunol"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X26000287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X26000287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T03:58:28Z","timestamp":1788667108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X26000287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":207,"alternative-id":["S0268960X26000287"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2026.101389","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The humoral pathophysiology of immune thrombocytopenia: How close are we to patient-specific disease treatment?","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2026.101389","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101389"}}